↓ Skip to main content

Dove Medical Press

Pulmonary hypertension: diagnostic and therapeutic challenges

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
4 X users
patent
1 patent
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
150 Mendeley
Title
Pulmonary hypertension: diagnostic and therapeutic challenges
Published in
Therapeutics and Clinical Risk Management, August 2015
DOI 10.2147/tcrm.s74881
Pubmed ID
Authors

Isabel S Bazan, Wassim H Fares

Abstract

Pulmonary hypertension (PH) is a hemodynamic and pathophysiologic state that can be found in multiple conditions with associated symptoms of dyspnea, decreased exercise tolerance, and progression to right heart failure. The World Health Organization has classified PH into five groups. The first group is pulmonary arterial hypertension (PAH), which can be idiopathic, heritable, due to drugs and toxins, or associated with conditions such as connective tissue diseases, congenital heart disease, portal hypertension, and others. The development of PAH is believed to result from smooth muscle cells and endothelial dysfunction that impairs production of vasodilators, including nitric oxide and prostacyclin. The importance of distinguishing this group from the other groups of PH is that there are PAH-specific drugs that target the molecular pathways that are pathogenic in the vascular derangements, leading to arterial hypertension, which should not be used in the other forms of PH. Other groups of PH include PH due to left heart disease, lung disease, chronic thromboembolic disease, as well as a miscellaneous category. Echocardiography is used to screen for PH and has varying sensitivity and specificity in detecting PH. Additionally, the right heart pressures estimated during echocardiogram often differ from those obtained during confirmatory testing with right heart catheterization. The most challenging PH diagnosis is in a case that does not fit one group of PH, but meets criteria that overlap between several groups. This also makes the treatment challenging because each group of PH is managed differently. This review provides an overview of the five groups of PH and discusses the diagnostic and therapeutic challenges of each.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Italy 1 <1%
Brazil 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 145 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 27 18%
Student > Master 25 17%
Other 15 10%
Student > Postgraduate 12 8%
Student > Ph. D. Student 10 7%
Other 25 17%
Unknown 36 24%
Readers by discipline Count As %
Medicine and Dentistry 72 48%
Biochemistry, Genetics and Molecular Biology 10 7%
Nursing and Health Professions 7 5%
Agricultural and Biological Sciences 7 5%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 11 7%
Unknown 37 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2023.
All research outputs
#4,158,501
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#199
of 1,323 outputs
Outputs of similar age
#49,186
of 276,425 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#5
of 49 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,425 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.